Search results
Author(s):
Devi Nair
Added:
4 weeks ago
AF Symposium 2026 - Dr Devi Nair (St Bernards Heart & Vascular, US) joins us to discuss early outcomes from the VERITAS Study, evaluating Abbott's next-generation Amulet 360™ Left Atrial Appendage Occluder for stroke prevention in patients with non-valvular atrial fibrillation.This pivotal study enrolled 400 patients across 34 centers in the United States, Canada, and Europe. Findings presented…
View more
Author(s):
Josep Rodés-Cabau
Added:
4 months ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device…
View more
Transseptal Access After Interatrial Shunt Devices: Try Everything Once and Great Things Twice
Author(s):
Molly Silkowski
,
Nicholas Amoroso
Added:
2 years ago
Abstract
Jacqueline Saw
Research Area(s) / Expertise:
Job title: Clinical Associate Professor
Author
Ole De Backer
Research Area(s) / Expertise:
Job title: Professor of Medicine and Cardiology
Author
AHA 24: The OPTION Trial
Author(s):
Oussama M Wazni
Added:
1 year ago
Video
Douglas Muir
Job title: Consultant Interventional Cardiologist
Author
Sacha Salzberg
Author
Simon Cheung-Chi Lam
Job title: Interventional Cardiologist
Author
Author(s):
Nicolas M Van Mieghem
Added:
4 months ago
NVM Cardiology Conference Reflections: What’s Hot at AHA 2025?Join Prof Nicolas Van Mieghem, Transcatheter Interventions Online Course Director, as he shares his perspective on the most anticipated late-breaking science from AHA 2025; the year’s defining moments in structural, coronary therapeutics.What transformative data should we expect at this year’s meeting? Which studies will challenge…
View more